Found 132 matching trials
Convalescent Plasma to Limit SARS-CoV-2 Associated Complications PHASE2 To assess the efficacy and safety of Human coronavirus immune plasma (HCIP)...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Convalescent Plasma for Treatment of COVID-19 PHASE2 Convalescent plasma has been shown to be safe and effective for treatment o...
Show More Location
Department of Infectious Disease, Falu Hospital
Learn More & Join Trial
Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients PHASE2 Severe ill Patients will be enrolled in the study (n=310) after duly filled...
Show More Location
Dow University of Health Sciences
Learn More & Join Trial
An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients N/A This is an observational study designed to learn more about how COVID19 con...
Show More Location
Children's Hospital Colorado
Learn More & Join Trial
Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019) PHASE1 This pilot, prospective study will assess the safety and efficacy of COVID-...
Show More Location
Houston Methodist Hopsital
Learn More & Join Trial
Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19 N/A The purpose of this study is to assess whether convalescent plasma therapy ...
Show More Location
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Learn More & Join Trial
Convalescent Plasma Transfusion in Severe COVID-19 Patients in Jamaica PHASE2 Corona virus Disease 2019 (COVID-19) can be a severe respiratory illness ca...
Show More Location
University of the West Indies
Learn More & Join Trial
Convalescent Plasma to Limit Coronavirus Associated Complications PHASE2 Researchers are trying to assess the treatment potential and safety of anti...
Show More Location
Multiple Locations
Learn More & Join Trial
Study Testing Convalescent Plasma vs Best Supportive Care PHASE1 Currently there are no proven treatment option for COVID-19. Human convales...
Show More Location
Multiple Locations
Learn More & Join Trial
Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals PHASE2 This study is a 4-arm, multicenter, randomized, partly double- blind, contr...
Show More Location
Abteilung Infektiologie Klinik für Innere Medizin II Department Innere Medizin Universitätsklinikum Freiburg
Learn More & Join Trial